Former Purdue Execs Fight Exclusion From Gov't Programs After OxyContin Case

The three former Purdue Pharma executives who pled guilty to misbranding OxyContin are battling the government for the ability to work in the health care sector. They have sued HHS for barring them from participation in government health programs for 12 years

More from Archive

More from Pink Sheet